TABLE 2.
Primers used in this studya
Name | Sequence (5′→3′) |
---|---|
PR-1 | 5′-GCCGAAGAGAACACAGATTTAGCCCA |
PR-2 | 5′-CCGCACGATGAAGAGCAGAAGTT |
PR-3 | 5′-CAGATCTCTGGAAAACGGGAAAGG |
PF-1 | 5′-AGAGAACACAGATTTAGCCCAGTCGG |
PF-2 | 5′-CCGCACGATGAAGAGCAGAAGTTAT |
PF-3 | 5′-GATCCTGGAAAACGGGAAAGGTTC |
TH22-10F1 | 5′-GAGCATGGTGTAACAGAAGAACAG |
TH22-10F2 | 5′-CTTCGTCCATGTAGTGGTGATTC |
TH22-10F3 | 5′-GGGTTGTACTAATGTCTGTAAACG |
TH22-10F4 | 5′-CTTCGTCCATGTAGTGGTGATT |
TH22-10R1 | 5′-GAATCACCACTACATGGACGAAG |
TH22-10R2 | 5′-CTGTTCTTCTGTTACACCATGCTC |
TH22-10R3 | 5′-AATCACCACTACATGGACGAAG |
TH22-10R4 | 5′-CGTTTACAGACATTAGTACAACCC |
TH22-10R5 | 5′-GTGATCGGCCTGATAACTTCC |
TH22-10R6 | 5′-TTGTCGTGAGCGTCCAATG |
TH22-10R7 | 5′-CATCAAGCAAGTTAACAGGCAAC |
TH22-10R8 | 5′-TCTCCGGAAACACCAGAATG |
TH22-10R9 | 5′-CTCTTCCGCCATTGGTATTC |
TH22-10R10 | 5′-TTCATCTGATGTGTCAGTGCC |
TH22-10R11 | 5′-TGATTGGCCTGAGCTACAGC |
TH22-10R12 | 5′-TGCCGTACCTGCCATTACC |
N-1 | 5′-NGTCGA(G/C)(A/T)GANA(A/T)GAA |
N-2 | 5′-GTNCGA(C/G)(A/T)CANA(A/T)GTT |
N-3 | 5′-(A/T)GTGNAG(A/T)ANCANAGA |
P-3 | 5′-CTCGACGTTGTCACTGAAGCGGGAAG |
P-4 | 5′-AAAGCACGAGGAAGCGGTCAGCCCAT |
PCAR-R2 | 5′-TCAATCTGGCATCGATAACAGGG |
PCAR-F2 | 5′-TGCTGGATCCAGCTTACGTGG |
PCAR-F3 | 5′-GGTTGTACTAATGTCTGTAAACG |
PCAR-R3 | 5′-CGTTTACAGACATTAGTACAACC |
All primers were purchased from MD Bio Inc., Taipei, Taiwan.